CDCM Cell and Gene Therapy Industrial Affiliates Program

The Stanford Center for Definitive and Curative Medicine (CDCM) Cell and Gene Therapy Industrial Affiliates Program provides a structure for companies to collaborate with our faculty to advance innovation in cell and gene therapy. Our program is designed to foster partnerships between industry and academia, promoting the development of cutting-edge technologies that have the potential to transform healthcare. The program provides holistic support for innovation, educating, commercializing, and administrative activities conducted by CDCM researchers.

The Affiliate Program is a membership program that offers valuable benefits to our industry partners. Members have opportunities to attend events where they can learn from and network with other cell and gene therapy professionals. They will also have access to our team of experts in regenerative medicine, cell biology, and gene editing, including clinicians, as research progresses from early stage. This access provides a unique opportunity to gain early insight as the science progresses. Strategic Level members have the opportunity to collaborate on projects and initiatives that are aligned with their business objectives.

*The site presentations and all information, data, and results arising from such visitation interactions will be shared with all members and the public.

Affiliate Program members may provide additional funding. All research results arising from the use of the additional funding will be shared with all program members and the general public. Affiliate Program members may request the additional funding be used to support a particular area of program research identified on the program’s website, or the program research of a named faculty member, as long as the faculty is identified on the program website as participating in the Affiliate Program. In either instance, the director of the Affiliate Program will determine how the additional funding will be used in the program’s research.

The site presentations and all information, data, and results arising from such visitation interactions will be shared with all members and the public.

Lead faculty will be Matthew Porteus, MD, PhD, Director, Center for Definitive and Curative Medicine and Anthony Oro, MD, PhD, Co-Director, Center for Definitive and Curative Medicine. Other faculty within the CDCM will participate ad hoc in the program based on interests and expertise.

Corporate members provide annual membership fees with an expected three-year commitment. All memberships are subject to Stanford University Policies for Industry Affiliates Programs. Please see the Stanford Research Policy Handbook for details. Information on the Stanford University visiting scholar program can be found here.

Member applications are accepted year-round. 

For more information and to apply, please contact our team at cdcm_contact@stanford.edu